Opdivo Plus Chemotherapy Approved for Treatment of Gastric Cancer

TUESDAY, April 20, 2021 -- Opdivo (nivolumab) is now approved for the treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, the U.S. Food and Drug Administration announced Friday. The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news